Bioventus Inc. misses on earnings expectations. Reported EPS is $0.04583 EPS, expectations were $0.215. Operator: Good day, and welcome to the Bioventus Inc. Third Quarter 2025 Earnings Conference ...

Breaking down performance by business segment reveals growth across all core areas: Pain Treatments revenue grew 6% to $67 million, accelerating from the first half of the year with strong volume ...

By segment, Pain Treatments revenue grew 6.4% to $67.2 million, driven by strong U.S. demand for Durolane, while Surgical Solutions revenue increased 9.3% to $50.2 million. Restorative Therapies ...

Bioventus Inc. (NASDAQ:BVS) is one of the best undervalued medical device stocks to buy now. On July 7, Cantor Fitzgerald analyst Ross Osborn initiated coverage of Bioventus Inc. (NASDAQ:BVS) with an ...

CEO Rob Claypoole highlighted that Bioventus achieved first quarter revenue of $124 million, reflecting 5% organic growth. He emphasized the company's focus on three priorities: above-market revenue ...

Companies like KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH, and Juniper Biologics are advancing Viscosupplementation Devices, improving diagnosis and patient outcomes. DelveInsight’s ...

Bioventus Inc. (NASDAQ:BVS) Q4 2024 Earnings Call Transcript March 11, 2025 Bioventus Inc. beats earnings expectations.

Bioventus Inc. posted strong Q2 results, with revenue up 10.3% and a raised full-year sales forecast. The company focuses on orthobiologics and active healing products, with key products like DUROLANE ...

The global Hyaluronic Acid Products Market is projected to reach a staggering USD 6.84 billion by 2033, reflecting a robust CAGR (Compound Annual Growth Rate) of 7.4%. This significant growth builds ...

The Global Hyaluronic Acid Products Industry is poised for exceptional growth, with a projected valuation of US$6,838.2 million by 2033, according to a recent market analysis by FMI. The industry is ...

DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, has agreed to a nationwide contract with ...